Status:
UNKNOWN
Study of Treatment Choice in Patients With Localized Prostate Cancer
Lead Sponsor:
University College London Hospitals
Conditions:
Prostate Cancer
Eligibility:
MALE
45-80 years
Phase:
NA
Brief Summary
RATIONALE: Gathering information about patients with prostate cancer may help doctors learn more about how patients choose treatment options. PURPOSE: This study is looking at treatment choice in pat...
Detailed Description
OBJECTIVES: Primary * To evaluate the importance of prostate cancer treatment characteristics to men with localized prostate cancer. * To determine to what extent men will choose the strengths and w...
Eligibility Criteria
Inclusion
- DISEASE CHARACTERISTICS:
- Histological diagnosis of adenocarcinoma of the prostate on transrectal or transperineal template prostate biopsies
- Clinical stage ≤ T2c N0 M0 (radiological T3a allowed)
- Local staging imaging as per guidelines to demonstrate localized disease (e.g., MRI, CT, and/or bone scan)
- No metastatic disease or nodal disease outside the prostate on bone scan or cross-sectional imaging
- No prior prostate surgery for cancer control (e.g., radical prostatectomy, high-intensity focused ultrasound ablation, cryosurgery, or photodynamic therapy) or other treatment for prostate cancer
- Gleason grade ≤ 7
- Serum PSA ≤ 15 ng/mL
- PATIENT CHARACTERISTICS:
- Not specified
- PRIOR CONCURRENT THERAPY:
- See Disease Characteristics
- No prior radiotherapy
- No androgen suppression/hormone treatment within the previous 12 months for prostate cancer
Exclusion
Key Trial Info
Start Date :
September 1 2010
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
Estimated Enrollment :
432 Patients enrolled
Trial Details
Trial ID
NCT01177865
Start Date
September 1 2010
Last Update
August 26 2013
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University College of London Hospitals
London, England, United Kingdom, WIT 3AA